"Trypanosomiasis, African" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces "African sleeping sickness." Nagana is a rapidly fatal trypanosomiasis of horses and other animals.
| Descriptor ID |
D014353
|
| MeSH Number(s) |
C03.752.300.900.719
|
| Concept/Terms |
Trypanosomiasis, African- Trypanosomiasis, African
- African Trypanosomiases
- Trypanosomiases, African
- African Trypanosomiasis
- African Sleeping Sickness
- African Sleeping Sicknesses
- Sickness, African Sleeping
- Sicknesses, African Sleeping
- Sleeping Sickness, African
- Sleeping Sicknesses, African
|
Below are MeSH descriptors whose meaning is more general than "Trypanosomiasis, African".
Below are MeSH descriptors whose meaning is more specific than "Trypanosomiasis, African".
This graph shows the total number of publications written about "Trypanosomiasis, African" by people in this website by year, and whether "Trypanosomiasis, African" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 5 | 2 | 7 |
| 2018 | 5 | 0 | 5 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Trypanosomiasis, African" by people in Profiles.
-
Demonstrating the sustainability of capacity strengthening amidst COVID-19. Int Health. 2021 09 03; 13(5):480-481.
-
Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo. Trans R Soc Trop Med Hyg. 2021 03 06; 115(3):245-252.
-
Clinical management of East African trypanosomiasis in South Africa: Lessons learned. Int J Infect Dis. 2018 Oct; 75:101-108.
-
Assessing Strategies Against Gambiense Sleeping Sickness Through Mathematical Modeling. Clin Infect Dis. 2018 06 01; 66(suppl_4):S286-S292.
-
The impact of passive case detection on the transmission dynamics of gambiense Human African Trypanosomiasis. PLoS Negl Trop Dis. 2018 04; 12(4):e0006276.
-
A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda. Parasit Vectors. 2018 02 22; 11(1):105.
-
Oral fexinidazole for human African trypanosomiasis. Lancet. 2018 01 13; 391(10116):100-102.
-
A Phase III Diagnostic Accuracy Study of a Rapid Diagnostic Test for Diagnosis of Second-Stage Human African Trypanosomiasis in the Democratic Republic of the Congo. EBioMedicine. 2018 Jan; 27:11-17.
-
Metabolic Profiling of Central Nervous System Disease in Trypanosoma brucei rhodesiense Infection. J Infect Dis. 2017 12 05; 216(10):1273-1280.
-
Sleeping sickness can now be cured with pills. Nature. 2017 10 18; 550(7677):441.